Skip to main content

Want a detailed portfolio tracker?

Evaxion Biotech A/S (EVAX) P/E (2021 - 2026)

Evaxion Biotech A/S (EVAX) P/E from Feb 5, 2021 to Jun 3, 2026. The TTM Evaxion Biotech A/S (EVAX) P/E is -8.11. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Evaxion Biotech A/S (EVAX)

YearP/EChange
2026-8.11+57.09%
2025-5.16+70.66%
2024-3.03-97.68%
2023-130.37-61.37%
2022-337.47-59.84%
2021-840.35N/A

Comparison Evaxion Biotech A/S (EVAX) P/E with competitors

Evaxion Biotech A/S (EVAX) P/E is -8.11.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.10-101.26%
ENLVEnlivex Therapeutics Ltd0.15-101.85%
FGENFibroGen Inc0.24-102.96%
TRAWTraws Pharma Inc0.47-105.83%
FBIOFortress Biotech Inc0.71-108.70%
CHRSCoherus Biosciences Inc0.98-112.06%
ORMPOramed Pharmaceuticals Inc1.47-118.17%
AGENAgenus Inc2.05-125.25%
VIVSVivoSim Labs Inc2.54-131.26%
INVAInnoviva Inc3.19-139.31%
CRMDCorMedix Inc3.65-144.95%
ABEOAbeona Therapeutics Inc4.20-151.84%
VXRTVaxart Inc4.26-152.54%
CVACCureVac N.V.4.45-154.81%
SRPTSarepta Therapeutics Inc4.62-157.01%
GLPGGalapagos NV4.86-159.90%
RIGLRigel Pharmaceuticals4.92-160.65%
ZVRAZevra Therapeutics Inc4.97-161.32%
ABUSArbutus Biopharma Corp5.69-170.20%
CGENCompugen Ltd7.38-191.03%
AUPHAurinia Pharmaceuticals Inc9.25-214.06%
ACADAcadia Pharmaceuticals Inc9.59-218.21%
OMEROmeros Corporation9.88-221.85%
PLXProtalix BioTherapeutics Inc9.91-222.17%
SPROSpero Therapeutics Inc10.73-232.34%
ADMAAdma Biologics Inc11.33-239.69%
SVASinovac Biotech Ltd11.44-240.99%
TBPHTheravance Biopharma Inc11.78-245.19%
HRMYHarmony Biosciences Holdings Inc12.18-250.17%
TGTXTG Therapeutics Inc13.18-262.48%
INCYIncyte Corp13.38-264.98%
SABSSAB Biotherapeutics Inc14.06-273.31%
XOMAXOMA Corp14.95-284.26%
REGNRegeneron Pharmaceuticals Inc14.98-284.69%
PBYIPuma Biotechnology Inc15.05-285.55%
EXELExelixis Inc15.79-294.73%
NAGENiagen Bioscience Inc16.35-301.64%
CPRXCatalyst Pharmaceuticals Inc17.34-313.84%
MDXGMimedx Group Inc17.38-314.22%
ARGXArgen X SE23.07-384.44%
HALOHalozyme Therapeutics Inc23.20-386.03%
XOMAOXOMA Corp25.34-412.47%
VRTXVertex Pharmaceuticals Inc25.66-416.30%
XOMAPXOMA Corp25.67-416.48%
CTMXCytomX Therapeutics Inc25.70-416.82%
ASNDAscendis Pharma A/S26.35-424.91%
RPRXRoyalty Pharma plc - Class A27.50-438.98%
SLNOSoleno Therapeutics Inc29.02-457.72%
LGNDLigand Pharmaceuticals Inc - Class B30.19-472.16%
BMRNBiomarin Pharmaceutical Inc37.51-562.42%
APLSApellis Pharmaceuticals Inc39.02-581.08%
KRYSKrystal Biotech Inc39.70-589.42%
GMABGenmab40.20-595.66%
ONCBeiGene Ltd67.03-926.36%
TECHBio-Techne Corp68.59-945.69%
VCELVericel Corp80.63-1094.06%
PHARPharming Group N.V.87.74-1181.72%
ALNYAlnylam Pharmaceuticals Inc124.93-1640.27%
TLXTelix Pharmaceuticals Ltd139.89-1824.67%
CORTCorcept Therapeutics Inc158.39-2052.74%